CSF3 and bacterial infectious disease: Granulocyte-colony stimulating factor (G-CSF) (Lenograstim, Neutrojin, Chugai Pharmaceutical Co., Ltd., Japan) (2 μg/kg) was subcutaneously administered to prevent bacterial infection.